Pillstats
Rx only · Tablet · Oral

Levothyroxine And Liothyronine

Brands: Evexithroid · Renthyroid · Levothyroxine + Liothyronine

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)10572
US makers2 labelers
Packages31
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.233$0.467$0.700$0.934Jan 2026Apr 2026Jul 2026
$0.796
Latest avg · Jul 22, 2026
-2%
Since Jan 21, 2026
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it2 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Genus Lifesciencesunknown23SUPPLYING
Trifluent Pharma LLCunknown8SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.